From a regulatory and distribution perspective medicinal cannabis is a prescription drug, just like good old pharma drugs.
The regulatory pathway is still being defined for these products we are trialling, so I feel an ex chairman of MA is a valuable addition to the team
Ann: Leading pharmaceutical executive to be appointed as Chairman, page-6
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable